Status: current, Sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jan 2018. Module: SNOMED CT core
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 3528361015 | PCSK9 inhibitor | en | Synonym (core metadata concept) | Active | Entire term case sensitive (core metadata concept) | SNOMED CT core |
| 3528362010 | Substance with proprotein convertase subtilisin/kexin type 9 inhibitor mechanism of action | en | Synonym (core metadata concept) | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
| 3528363017 | Substance with proprotein convertase subtilisin/kexin type 9 inhibitor mechanism of action (substance) | en | Fully specified name | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| PCSK9 inhibitor | Is a | Hydrolase inhibitor | true | Inferred relationship | Some | ||
| PCSK9 inhibitor | Has disposition (attribute) | Proprotein convertase subtilisin/kexin type 9 inhibitor (disposition) | true | Inferred relationship | Some | ||
| PCSK9 inhibitor | Is a | Enzyme inhibitor | false | Inferred relationship | Some | ||
| PCSK9 inhibitor | Is a | Drug or medicament (substance) | true | Inferred relationship | Some |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
| Alirocumab (substance) | Is a | True | PCSK9 inhibitor | Inferred relationship | Some | |
| Evolocumab (substance) | Is a | True | PCSK9 inhibitor | Inferred relationship | Some | |
| Product containing proprotein convertase subtilisin/kexin type 9 inhibitor (product) | Has active ingredient | True | PCSK9 inhibitor | Inferred relationship | Some | 1 |
| Inclisiran (substance) | Is a | True | PCSK9 inhibitor | Inferred relationship | Some | |
| Inclisiran sodium (substance) | Is a | True | PCSK9 inhibitor | Inferred relationship | Some |
This concept is not in any reference sets
FHIR